Indirect MAIPA with serum and IgG fractions, in the absence and presence of gold
Case . | Serum . | Purified IgG . | ||||||
---|---|---|---|---|---|---|---|---|
Native sample . | Gold (μg/mL)* . | Native sample . | Gold (μg/mL) . | |||||
0.1 . | 1 . | 10 . | 0.1 . | 1 . | 10 . | |||
Control† | 0.01‡ | 0.00 | 0.00 | 0.00 | 0.15 | 0.12 | 0.13 | 0.12 |
2 | 0.43 | 0.34 | 0.36 | 0.30 | 0.49 | 0.41 | 0.23 | 0.39 |
3 | 1.39 | 1.14 | 1.93 | 1.04 | 0.46 | 0.31 | 0.35 | 0.23 |
4 | 0.38 | 0.28 | 0.39 | 0.23 | 0.34 | 0.19 | 0.27 | 0.17 |
7 | 0.33 | 0.24 | 0.24 | 0.18 | 0.56 | 0.48 | 0.48 | 0.53 |
8 | 1.12 | 0.95 | 1.02 | 0.97 | 1.74 | 1.40 | 1.45 | 1.32 |
Case . | Serum . | Purified IgG . | ||||||
---|---|---|---|---|---|---|---|---|
Native sample . | Gold (μg/mL)* . | Native sample . | Gold (μg/mL) . | |||||
0.1 . | 1 . | 10 . | 0.1 . | 1 . | 10 . | |||
Control† | 0.01‡ | 0.00 | 0.00 | 0.00 | 0.15 | 0.12 | 0.13 | 0.12 |
2 | 0.43 | 0.34 | 0.36 | 0.30 | 0.49 | 0.41 | 0.23 | 0.39 |
3 | 1.39 | 1.14 | 1.93 | 1.04 | 0.46 | 0.31 | 0.35 | 0.23 |
4 | 0.38 | 0.28 | 0.39 | 0.23 | 0.34 | 0.19 | 0.27 | 0.17 |
7 | 0.33 | 0.24 | 0.24 | 0.18 | 0.56 | 0.48 | 0.48 | 0.53 |
8 | 1.12 | 0.95 | 1.02 | 0.97 | 1.74 | 1.40 | 1.45 | 1.32 |
Native samples are samples without gold added.
Final concentration of gold during all stages of MAIPA. For clarity, results using 100 μg/mL are not shown.
Negative control AB serum or IgG fraction from AB serum.
ELISA OD values. Results are from a representative experiment, derived from duplicate testing against platelets from 2 donors.